Stella Diagnostics (Stella Diagnostics) EV-to-EBITDA : (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Stella Diagnostics's enterprise value is $26.23 Mil. Stella Diagnostics does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-EBITDA at this moment.

The historical rank and industry rank for Stella Diagnostics's EV-to-EBITDA or its related term are showing as below:

SLDX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -65.47 Med: 0 Max: 0
Current: -33.76

SLDX's EV-to-EBITDA is ranked worse than
100% of 112 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.38 vs SLDX: -33.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Stella Diagnostics's stock price is $0.052. Stella Diagnostics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Stella Diagnostics EV-to-EBITDA Historical Data

The historical data trend for Stella Diagnostics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics EV-to-EBITDA Chart

Stella Diagnostics Annual Data

Trend

EV-to-EBITDA

Stella Diagnostics Quarterly Data
	Sep22	Sep23
EV-to-EBITDA	-	-

Competitive Comparison of Stella Diagnostics's EV-to-EBITDA

For the Diagnostics & Research subindustry, Stella Diagnostics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's EV-to-EBITDA falls into.

Stella Diagnostics EV-to-EBITDA Calculation

Stella Diagnostics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	26.232	/
	=

Stella Diagnostics (OTCPK:SLDX) EV-to-EBITDA Explanation

Stella Diagnostics's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.052	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Stella Diagnostics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.